Dr. Mandy Leonard, Senior Director of Drug Use Policy and Formulary Management at Cleveland Clinic and Steven Lucio, Senior Principal in Pharmacy Solutions at Vizient discuss their insights on the approval, role, and coverage of Aducanumab, the first drug in a new class approved for Alzheimer’s by the FDA’s accelerated approval process.

Guest speakers:

Steven Lucio, PharmD, BCPS

Moderator:

Show Notes:

[01:20 -4:16] How aducanumab fits into the treatment of Alzheimer's disease

[04:17-8:29] Accelerated Approval process and Aducanumab

[08:30-14:38] Aducanumab trials and efficacy

[14:39-17:24] Aducanumab trials and safety

Links | Resources:

EMERGE and ENGAGE

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Google Podcasts

Spotify

Stitcher

Android

RSS Feed